Traffikgene
Scientific entrepreneurism project (expected establishment of NewCo by Q4 2023) focused on the development of a new technology platform for the delivery of nucleic acid therapeutics. As a technology transference and valorization academic project from the Montenegro research group (Universidade de Santiago De Compostela / CIQUS), we have discovered a new peptide-based approach that enables efficient, non-toxic and targeted delivery of a wide variety of nucleic acids (mRNA, siRNA, pDNA) and proteins (Cas9). Robust in vitro and in vivo data suggest the potential for translation of this novel delivery technology into preclinical developments, which are currently being sought.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Traffikgene
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Traffikgene
3 distinct titles indexed · top 3 shown.
- 1research technician
- 1scientific entrepreneur
- 1synthetic chemist
Sign up to unlock all 3 contacts at Traffikgene
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Traffikgene
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.